Pfizer Inc
NYSE: PFE
$24.80
-$1.22 (-4.7%)
Closing Price on November 15, 2024
PFE Articles
3M, Pfizer, Caterpillar, and United Technologies posted the best gains among the Dow 30 stocks Tuesday.
Published:
Last Updated:
Pfizer released better-than-expected second-quarter financial results before the markets opened on Tuesday.
Published:
Last Updated:
Pfizer is scheduled to release its second-quarter financial results before the markets open on Tuesday.
Published:
Last Updated:
24/7 Wall St. has put together a preview of Apple, Pfizer and other Dow companies scheduled to report their quarterly results this week.
Published:
Last Updated:
The July 13 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
Pfizer and Eli Lilly shares were largely unaffected after the firms announced positive results from a joint late-stage trial in patients with osteoarthritis pain.
Published:
Last Updated:
The June 29 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
JetBlue orders planes from Airbus, Pfizer to defer some drug price increases, Toyota launches car-sharing service in Hawaii, and other important business headlines.
Published:
Last Updated:
The June 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
Pfizer shares slipped slightly on Monday morning after the firm announced results from its late-stage trial of breast cancer. Ultimately the results were positive but not exactly what the study was...
Published:
Last Updated:
Keep in mind that short sellers betting against big pharma are taking on an added risk. They have to pay out the ongoing high dividends on top of the cost of borrowing the shares.
Published:
Last Updated:
Pfizer shares were up marginally on Wednesday after the pharma giant announced that it would be committing over half a billion dollars to its venture capital arm.
Published:
Last Updated:
These four stocks may not be as safe as U.S. Treasury debt, but they still would make great additions to more conservative growth and income portfolios now.
Published:
Last Updated:
Pfizer announced early on Monday that it received a couple critical updates from the FDA related to its Xalkori (crizotinib).
Published:
Last Updated:
The May 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
Last Updated: